The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

gotherapeutics.com

Founded Year

2014

Stage

Series B | Alive

Total Raised

$25.5M

Last Raised

$20.5M | 1 mo ago

About Go Therapeutics

GO Therapeutics is exploiting aspects of cancer cell biology to develop a class of cancer therapies for previously intractable solid tumors. The company targets O-linked glycoproteins that are specific to cancer cells to develop high-affinity antibodies to cancer-specific targets. The company's antibodies are the basis for a broad array of potent cancer-killing modalities, including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue. Go Therapeutics was founded in 2014 and is based in Natick, Massachusetts.

Go Therapeutics Headquarter Location

22 Strathmore Road

Natick, Massachusetts, 01760,

United States

(800) 978-6543

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Go Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Go Therapeutics is included in 3 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Go Therapeutics Patents

Go Therapeutics has filed 7 patents.

The 3 most popular patent topics include:

  • Monoclonal antibodies
  • Clusters of differentiation
  • Experimental cancer drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/23/2018

11/2/2021

Clusters of differentiation, Monoclonal antibodies, Immunology, Immune system, Proteins

Grant

Application Date

10/23/2018

Grant Date

11/2/2021

Title

Related Topics

Clusters of differentiation, Monoclonal antibodies, Immunology, Immune system, Proteins

Status

Grant

Latest Go Therapeutics News

Astellas enters strategic collaboration with GO Therapeutics

Jun 2, 2022

01-06-2022 Japanese drug major Astellas Pharma’s (TYO: 4503) subsidiary Xyphos Biosciences and Cambridge, Massachusetts-based GO Therapeutics have entered into a strategic research collaboration and license agreement to develop novel immuno-oncology therapeutics. GO is applying new advances in glycoproteomics to develop antibody-based cancer therapeutics that specifically target cancer cells. Xyphos holds a novel and proprietary ACCELTM technology… This article is accessible to registered users, to continue reading please register for free . A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please  login . If your trial has come to an end, you can  subscribe here. • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results. • Daily roundup of key events in pharma and biotech. • Monthly in-depth briefings on Boardroom appointments and M&A news. • Choose from a cost-effective annual package or a flexible monthly subscription. If you are already a registered user please login . The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed Chairman, Sanofi Aventis UK

  • When was Go Therapeutics founded?

    Go Therapeutics was founded in 2014.

  • Where is Go Therapeutics's headquarters?

    Go Therapeutics's headquarters is located at 22 Strathmore Road, Natick.

  • What is Go Therapeutics's latest funding round?

    Go Therapeutics's latest funding round is Series B.

  • How much did Go Therapeutics raise?

    Go Therapeutics raised a total of $25.5M.

  • Who are the investors of Go Therapeutics?

    Investors of Go Therapeutics include Astellas Pharma, Roche Holding and Salubris Pharmaceuticals.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.